BioNet News, Pertussis, Publication 01 Nov 2018 The Lancet : Infectious Diseases Vaccines containing formalin-inactivated whole-cell Bordetella pertussis strains were first developed in the USA in the 1930s, and manufacturing processes were… Supachai
BioNet News, Pertussis, Press Releases 01 Nov 2018 BioNet acellular pertussis vaccines Publications report Paris, France - BioNet announced today that the one-year antibody persistence results from the phase 2/3 randomized controlled trial of its… Supachai
BioNet News, Pertussis, Press Releases 05 Sep 2018 Boosting Pertussis Vaccination PARIS, GENEVA and BANGKOK September 5, 2018 - DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT),… Supachai
BioNet News, Dengue, Press Releases 19 Jun 2018 In-Cell-Art, Institut Pasteur & BioNet-Asia fight against the Dengue virus Nantes / Paris / France, 19th of June, 2018 - In-Cell-Art (ICA), a biotechnology company specialized in nanocarrier technologies, BioNet-Asia (BNA), an… Supachai